We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ultrasonic Measurements of the Clitoris in Fetuses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01011400
Recruitment Status : Withdrawn
First Posted : November 11, 2009
Last Update Posted : August 28, 2013
Information provided by (Responsible Party):
Meir Medical Center

Brief Summary:
Abnormal enlargement of the clitoris in fetal life may be a sign for different pathologies. To the investigators knowledge there is no published nomogram of the clitoris size through gestation and it's assessment is usually subjective. The purpose of this study is to create a nomogram of clitorial size through gestation by measuring its size in fetuses of different age in the second and third trimester.

Condition or disease
Ambiguous Genitalia

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Measurements of the Fetal Clitoris by 2D Ultrasound
Study Start Date : November 2009
Estimated Primary Completion Date : December 2011
Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   14 Weeks to 37 Weeks   (Child)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
pregnant women with a female fetus in the second or 3 ed trimester

Inclusion Criteria:

  • well dated pregnancy
  • singleton pregnancy
  • female fetus
  • appropriate for gestational age

Exclusion Criteria:

  • small for gestational age
  • other fetal anomalies
  • maternal conditions that can cause exposure of the fetus to high androgen environment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01011400

Meir Medical Center
Kfar Saba, Israel
Sponsors and Collaborators
Meir Medical Center

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01011400     History of Changes
Other Study ID Numbers: 121-09
First Posted: November 11, 2009    Key Record Dates
Last Update Posted: August 28, 2013
Last Verified: August 2013

Keywords provided by Meir Medical Center:

Additional relevant MeSH terms:
Disorders of Sex Development
Urogenital Abnormalities
Congenital Abnormalities
Gonadal Disorders
Endocrine System Diseases